Biogen taps insider Vounatsos to succeed CEO Scangos

Biogen Inc. (NASDAQ:BIIB) said EVP and Chief Commercial Officer Michel Vounatsos will succeed George Scangos as CEO, effective Jan. 6, 2017. Biogen said in July that Scangos would retire once the company identified a successor (see BioCentury Extra, July 21).

Vounatsos joined Biogen in April following a 20-year career at Merck, including leadership positions in Europe and China...